A procedure was developed for preparing di[methoxy(ethoxy)carbonylamino-1H-benzimidazol-5-yl] ethers by the reaction of methyl or ethyl chloroformate with sodium cyanamide, followed by the reaction of the resulting methyl or ethyl cyanocarbamate with 4-(3,4-diaminophenoxy)-1,2-phenylenediamine in acidic solution.Although numerous 2-aminobenzimidazole derivatives were prepared and tested for the biological activity [1311], search for new antihelminth agents among these compounds remains an urgent problem.It is known [12] that methyl (1H-benzimidazol-2-yl)carbamate exhibits, along with high antihelminth activity, also noticeable embryotoxicity. As follows from the existing views on the mechanism of the side effect of this compound [12,13], introduction of a ÄÄÄÄÄÄÄÄÄÄÄÄ substituent at the 5-position may reduce or eliminate the side effects. Therefore, we developed a procedure for preparing di[methoxy(ethoxy)carbonylamino-1H-benzimidazol-5-yl] ethers I and II.The synthesis involves preparation of 4-(4-nitrophenoxy)phenylamine III, its acylation with acetic anhydride to obtain N- [4-(4-nitrophenoxy)phenyl]-acetamide IV, and its subsequent transformations (Scheme 1). Scheme 1. 3 cc H 2 N ONa + 3 cc Cl NO 2 %%$ K 2 CO 3 3 cc H 2 N O 3 cc NO 2 III %%$ Ac 2 O 3 cc O 3 cc NO 2 IV AcHN %%%$ H 2 NNH 2 3 cc O 3 cc NH 2